BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34652819)

  • 1. An anthropomorphic pelvis phantom for MR-guided prostate interventions.
    Bauer DF; Adlung A; Brumer I; Golla AK; Russ T; Oelschlegel E; Tollens F; Clausen S; Aumüller P; Schad LR; Nörenberg D; Zöllner FG
    Magn Reson Med; 2022 Mar; 87(3):1605-1612. PubMed ID: 34652819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technical Note: ADAM PETer - An anthropomorphic, deformable and multimodality pelvis phantom with positron emission tomography extension for radiotherapy.
    Gillmann C; Homolka N; Johnen W; Runz A; Echner G; Pfaffenberger A; Mann P; Schneider V; Hoffmann AL; Troost EGC; Koerber SA; Kotzerke J; Beuthien-Baumann B
    Med Phys; 2021 Apr; 48(4):1624-1632. PubMed ID: 33207020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 3: Targeted Biopsy.
    Venderink W; Bomers JG; Overduin CG; Padhani AR; de Lauw GR; Sedelaar MJ; Barentsz JO
    Eur Urol; 2020 Apr; 77(4):481-490. PubMed ID: 31791623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ADAM-pelvis phantom-an anthropomorphic, deformable and multimodal phantom for MRgRT.
    Niebuhr NI; Johnen W; Echner G; Runz A; Bach M; Stoll M; Giske K; Greilich S; Pfaffenberger A
    Phys Med Biol; 2019 Feb; 64(4):04NT05. PubMed ID: 30630152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging/transrectal ultrasonography fusion guided seed placement in a phantom: Accuracy between 2-seed versus 1-seed strategies.
    Li Q; Duan Y; Baikpour M; Pierce TT; McCarthy CJ; Thabet A; Chan ST; Samir AE
    Eur J Radiol; 2020 Aug; 129():109126. PubMed ID: 32544805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
    Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC
    Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of Serial Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging-guided Biopsies in Men with Low-risk Prostate Cancer on Active Surveillance After 1 Yr Follow-up.
    Hamoen EHJ; Hoeks CMA; Somford DM; van Oort IM; Vergunst H; Oddens JR; Smits GA; Bokhorst LP; Witjes JA; Rovers MM; Hulsbergen-van de Kaa CA; Barentsz JO
    Eur Urol Focus; 2019 May; 5(3):407-415. PubMed ID: 29331622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. End-to-end test for fractionated online adaptive MR-guided radiotherapy using a deformable anthropomorphic pelvis phantom.
    Elter A; Rippke C; Johnen W; Mann P; Hellwich E; Schwahofer A; Dorsch S; Buchele C; Klüter S; Karger CP
    Phys Med Biol; 2021 Dec; 66(24):. PubMed ID: 34845991
    [No Abstract]   [Full Text] [Related]  

  • 9. Development and evaluation of a novel MR-compatible pelvic end-to-end phantom.
    Cunningham JM; Barberi EA; Miller J; Kim JP; Glide-Hurst CK
    J Appl Clin Med Phys; 2019 Jan; 20(1):265-275. PubMed ID: 30411477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and evaluation of an anatomically correct multi-image modality compatible phantom for prostate cancer focal ablation.
    Lindner U; Lawrentschuk N; Weersink RA; Raz O; Hlasny E; Sussman MS; Davidson SR; Gertner MR; Trachtenberg J
    J Urol; 2010 Jul; 184(1):352-7. PubMed ID: 20488477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.
    van der Leest M; Cornel E; Israël B; Hendriks R; Padhani AR; Hoogenboom M; Zamecnik P; Bakker D; Setiasti AY; Veltman J; van den Hout H; van der Lelij H; van Oort I; Klaver S; Debruyne F; Sedelaar M; Hannink G; Rovers M; Hulsbergen-van de Kaa C; Barentsz JO
    Eur Urol; 2019 Apr; 75(4):570-578. PubMed ID: 30477981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An end-to-end test for MR-guided online adaptive radiotherapy.
    Hoffmans D; Niebuhr N; Bohoudi O; Pfaffenberger A; Palacios M
    Phys Med Biol; 2020 Jun; 65(12):125012. PubMed ID: 32294637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of a 2
    Bomers JGR; Bosboom DGH; Tigelaar GH; Sabisch J; Fütterer JJ; Yakar D
    Eur Radiol; 2017 Apr; 27(4):1776-1782. PubMed ID: 27436021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-T Multiparametric MRI Followed by In-Bore MR-Guided Biopsy for Detecting Clinically Significant Prostate Cancer After Prior Negative Transrectal Ultrasound-Guided Biopsy.
    Hosseiny M; Shakeri S; Felker ER; Lu D; Sayre J; Ahuja P; Raman SS
    AJR Am J Roentgenol; 2020 Sep; 215(3):660-666. PubMed ID: 32755166
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer.
    De Roover R; Crijns W; Poels K; Peeters R; Draulans C; Haustermans K; Depuydt T
    Med Phys; 2018 May; 45(5):2205-2217. PubMed ID: 29537613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging-guided prostate biopsy: present and future.
    Kim CK
    Korean J Radiol; 2015; 16(1):90-8. PubMed ID: 25598677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers.
    Hoeks CM; Schouten MG; Bomers JG; Hoogendoorn SP; Hulsbergen-van de Kaa CA; Hambrock T; Vergunst H; Sedelaar JP; Fütterer JJ; Barentsz JO
    Eur Urol; 2012 Nov; 62(5):902-9. PubMed ID: 22325447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. End-to-end empirical validation of dose accumulation in MRI-guided adaptive radiotherapy for prostate cancer using an anthropomorphic deformable pelvis phantom.
    Bohoudi O; Lagerwaard FJ; Bruynzeel AME; Niebuhr NI; Johnen W; Senan S; Slotman BJ; Pfaffenberger A; Palacios MA
    Radiother Oncol; 2019 Dec; 141():200-207. PubMed ID: 31585817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective comparison of direct in-bore magnetic resonance imaging (MRI)-guided biopsy and fusion-guided biopsy in patients with MRI lesions which are likely or highly likely to be clinically significant prostate cancer.
    Venderink W; van der Leest M; van Luijtelaar A; van de Ven WJM; Fütterer JJ; Sedelaar JPM; Huisman HJ
    World J Urol; 2017 Dec; 35(12):1849-1855. PubMed ID: 28871396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-clinical evaluation of an image-guided in-situ Raman spectroscopy navigation system for targeted prostate cancer interventions.
    Shams R; Picot F; Grajales D; Sheehy G; Dallaire F; Birlea M; Saad F; Trudel D; Menard C; Leblond F; Kadoury S
    Int J Comput Assist Radiol Surg; 2020 May; 15(5):867-876. PubMed ID: 32227280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.